1. Home
  2. VTGN vs DFLI Comparison

VTGN vs DFLI Comparison

Compare VTGN & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.26

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Logo Dragonfly Energy Holdings Corp. (NV)

DFLI

Dragonfly Energy Holdings Corp. (NV)

HOLD

Current Price

$1.74

Market Cap

25.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTGN
DFLI
Founded
1998
2020
Country
United States
United States
Employees
N/A
141
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
25.3M
25.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
VTGN
DFLI
Price
$0.26
$1.74
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$0.90
$3.25
AVG Volume (30 Days)
4.0M
355.3K
Earning Date
06-16-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$124.49
N/A
Revenue Next Year
$353.99
$51.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.15
52 Week High
$5.14
$5.15

Technical Indicators

Market Signals
Indicator
VTGN
DFLI
Relative Strength Index (RSI) 32.41 41.94
Support Level $0.20 $1.67
Resistance Level $0.66 $2.25
Average True Range (ATR) 0.05 0.14
MACD -0.03 -0.01
Stochastic Oscillator 10.27 9.37

Price Performance

Historical Comparison
VTGN
DFLI

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is engaged in the design, assembly, and sale of lithium-ion batteries, mainly lithium iron phosphate (LFP) batteries, for applications in recreational vehicles, marine, industrial, and other markets. The company operates through two segments: direct-to-consumer (DTC), which sells Battle Born branded batteries, and OEM, which supplies Dragonfly branded batteries to original equipment manufacturers.

Share on Social Networks: